Septerna (SEPN) Gains from Sales and Divestitures (2024 - 2026)
Septerna (SEPN) recorded quarterly Gains from Sales and Divestitures of $55977.0 in Q1 2026, down 87.36% quarter-over-quarter from $442993.0 in Q4 2025, and down 53.25% on a YoY basis from $119730.0 in Q1 2025.
Septerna (SEPN) Gains from Sales and Divestitures (2024 - 2026) Analysis & Trends
Septerna's Gains from Sales and Divestitures history runs 3 years deep, the most recent figure standing at $55977.0 for Q1 2026.
- In Q1 2026, Gains from Sales and Divestitures fell 53.25% year-over-year to $55977.0; the TTM figure through Mar 2026 stood at $55977.0 (down 53.25% YoY), while the FY2025 annual figure was $442993.0, up 7.81% from the prior year.
- Gains from Sales and Divestitures was $55977.0 for Q1 2026 at Septerna, down from $442993.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $442993.0 in Q4 2025 to a low of $55977.0 in Q1 2026.
- Historically, Gains from Sales and Divestitures has averaged $266059.1 across 3 years, with a median of $251493.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Gains from Sales and Divestitures surged 37.66% in 2025, then plunged 53.25% in 2026.
- A 3-year view of Gains from Sales and Divestitures shows it stood at $410916.0 in 2024, then advanced by 7.81% to $442993.0 in 2025, then slumped by 87.36% to $55977.0 in 2026.
- The last three Gains from Sales and Divestitures figures came in at $55977.0 (Q1 2026), $442993.0 (Q4 2025), and $346197.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55,977.00 |
| Mar 31, 2026 | 55,977.00 |
| Dec 31, 2025 | 442,993.00 |
| Dec 31, 2025 | 442,993.00 |
| Sep 30, 2025 | 346,197.00 |
| Sep 30, 2025 | 346,197.00 |
| Jun 30, 2025 | 235,108.00 |
| Jun 30, 2025 | 235,108.00 |
| Mar 31, 2025 | 119,730.00 |
| Mar 31, 2025 | 119,730.00 |
| Dec 31, 2024 | 410,916.00 |
| Dec 31, 2024 | 410,916.00 |
| Sep 30, 2024 | 251,493.00 |
| Sep 30, 2024 | 251,493.00 |